2,5,8,11-Tetraazatridecan-13-oic acid,8-(carboxymethyl)-11-[2-[[2-(dimethylamino)ethyl]amino]-2-oxoethyl]-2-methyl-6-oxo- (141096-71-1)

Identification
Name:	2,5,8,11-Tetraazatridecan-13-oic acid,8-(carboxymethyl)-11-[2-[[2-(dimethylamino)ethyl]amino]-2-oxoethyl]-2-methyl-6-oxo-
CAS:	141096-71-1
Molecular Formula:	C₁₈H₃₆N₆O₆
Molecular Structure:
Properties
Safety Data

Other Product

2,5,8,11-Tetraazatridecan-13-oic acid,11-(carboxymethyl)-8-[2-(hexadecyloxy)-2-oxoethyl]-2-methyl-6-oxo-,13-hexadecyl ester
2-Thia-5,8,11-triazatridecan-13-oic acid,8-(carboxymethyl)-11-[2-[[2-(methylthio)ethyl]amino]-2-oxoethyl]-6-oxo-
2,5,8,11-Tetraazatridecan-13-oic acid,1-(4-aminophenyl)-11-[2-[[(4-aminophenyl)methyl]amino]-2-oxoethyl]-5,8-bis(carboxymethyl)-3-oxo-, trisodium salt
2,5,8,11-Tetraazatridecan-13-oicacid, 5,8-bis(carboxymethyl)-11-[2-(methylamino)-2-oxoethyl]-3-oxo-
2,4,7,12-Tetraazatridecan-13-oic acid,10-hydroxy-2-methyl-5-(1-methylethyl)-1-[2-(1-methylethyl)-4-thiazolyl]-3,6-dioxo-8-(phenylmethyl)-11-(trifluoromethyl)-, 5-thiazolylmethyl ester
Calciate(1-),[5,8-bis(carboxymethyl)-11-[2-(methylamino)-2-oxoethyl]-3-oxo-2,5,8,11-tetraazatridecan-13-oato(3-)]-,sodium, hydrate (9CI)
2-Oxa-5,8,11-triazatridecan-13-oic acid,5,8-bis(carboxymethyl)-11-(2-methoxy-2-oxoethyl)-3-oxo-
Dysprosium,[5,8-bis[(carboxy-kO)methyl]-11- [2-(methylamino)-2-(oxo-kO)ethyl]-3-(oxo- kO)-2,5,8,11-tetraazatridecan-13-oato(3-)- kN5,kN8,kN11,kO13]-,mixt. with sodium [5,8-bis[(carboxy-kO)methyl]-11-[2-(methylamino)- 2-oxoethyl]-3-oxo-2,5,8,11-tetraazatridecan- 13-oato(3-)-kN5,kN8,kN11,kO13]- calciate(1-)
Calciate(1-),[5,8-bis[(carboxy-kO)methyl]-11-[2-(methylamino)-2-oxoethyl]-3-oxo-2,5,8,11-tetraazatridecan-13-oato(3-)-kN5,kN8,kN11,kO13]-, sodium (1:1)
Calciate(1-),[5,8-bis[(carboxy-kO)methyl]-11-[2-(methylamino)-2-oxoethyl]-3-oxo-2,5,8,11-tetraazatridecan-13-oato(3-)-kN5,kN8,kN11,kO13]-, hydrogen (9CI)
Gadolinium,[5,8-bis[(carboxy-kO)methyl]-11-[2-(methylamino)-2-(oxo-kO)ethyl]-3-(oxo-kO)-2,5,8,11-tetraazatridecan-13-oato(3-)-kN5,kN8,kN11,kO13]-
Dysprosium,[5,8-bis[(carboxy-kO)methyl]-11-[2-(methylamino)-2-(oxo-kO)ethyl]-3-(oxo-kO)-2,5,8,11-tetraazatridecan-13-oato(3-)-kN5,kN8,kN11,kO]- (9CI)
Gadolinium,[5,8-bis[(carboxy-kO)methyl]-11- [2-(methylamino)-2-(oxo-kO)ethyl]-3-(oxo- kO)-2,5,8,11-tetraazatridecan-13-oato(3-)- kN5,kN8,kN11,kO13]-
14-Oxa-2,8,11-triazahexadecanoic acid,8-[2-[bis[2-(1,1-dimethylethoxy)-2-oxoethyl]amino]ethyl]-7-[(1,1-dimethylethoxy)carbonyl]-11-[2-(1,1-dimethylethoxy)-2-oxoethyl]-15,15-dimethyl-13-oxo-, phenylmethyl ester, (7S)-
2-Oxa-5,8,11-triazatridecan-13-oic acid,8-(2-methoxy-2-oxoethyl)-4,5,11,12-tetramethyl-3-oxo-, methyl ester,(4S,12S)-
2,5,7,12-Tetraoxapentadec-9-en-15-oic acid,13-methyl-11-oxo-8-[(1S)-1-[(1-oxo-2-propenyl)oxy]ethyl]-,(1S,2R)-2-[(4-methoxyphenyl)methoxy]-1-methyl-3-butenyl ester,(8R,9E,13S)-
2,5,7,12-Tetraoxapentadec-9-en-15-oic acid,13-methyl-11-oxo-8-[(1S)-1-[(1-oxo-2-propenyl)oxy]ethyl]-,(1S,2R)-2-hydroxy-1-methyl-3-butenyl ester, (8R,9E,13S)-
2,4,7,12-Tetraazatridecan-13-oicacid,10-hydroxy-2-methyl-5-(1-methylethyl)-1-[2-(1-methylethyl)-4-thiazolyl]-3,6-dioxo-11-(phenylmethyl)-8-(5-thiazolylmethyl)-,5-thiazolylmethyl ester, [5S-(5R*,8R*,10R*,11R*)]- (9CI)
3,6,9,12,15-Pentaazaheptadecanoic acid,6,9-bis(carboxymethyl)-15-ethyl-3-[2-(nonylamino)-2-oxoethyl]-11-oxo-
2,5,7,12-Tetraoxapentadec-9-en-15-oic acid,8-[(1S)-1-[[(1,1-dimethylethyl)dimethylsilyl]oxy]ethyl]-13-methyl-11-oxo-,(1S,2R)-2-[(4-methoxyphenyl)methoxy]-1-methyl-3-butenyl ester,(8R,9E,13S)-